Associate DirectorLouisiana Center for Bleeding and Clotting Disorders, Tulane University Medical Center, LA, USANew Orleans, Louisiana, United States
PB0225 - Evaluation of Real-world Treatment Patterns and Outcomes in Patients with Von Willebrand Disease Treated Prophylactically with recombinant Von Willebrand Factor in the United States: Interim Analysis
Sunday, June 25, 202318:30 – 19:30 ET
PB0693 - Efficacy and Safety of Eptacog Beta (Recombinant Activated FVII) in Patients with Hemophilia A or B with Inhibitors According to Time to Initial Infusion: a Post-Hoc Analysis from PERSEPT-1
Monday, June 26, 202318:30 – 19:30 ET
PB1263 - Third Interim Subgroup Analysis of the Effectiveness and Safety of Damoctocog Alfa Pegol in Patients with Hemophilia A Treated Every 5 or Every 7 Days: Results from the Real-World HEM-POWR Study
Tuesday, June 27, 202318:30 – 19:30 ET
